Page last updated: 2024-08-17

levodopa and salicylates

levodopa has been researched along with salicylates in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19905 (55.56)18.7374
1990's1 (11.11)18.2507
2000's2 (22.22)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kelley, WN1
Altschule, MD; Hegedus, ZL1
Madan, PL1
Higuchi, T; Nishihata, T; Rytting, JH1
Kinst-Hori, I; Kubo, I; Yokokawa, Y1
Camp, DM; LeWitt, PA; Loeffler, DA1
Dryhurst, G; Foster, SB; Han, J; Wrona, MZ1
Borah, A; Mohanakumar, KP1

Reviews

1 review(s) available for levodopa and salicylates

ArticleYear
Effects of drugs on uric acid in man.
    Annual review of pharmacology, 1975, Volume: 15

    Topics: Antineoplastic Agents; Depression, Chemical; Diuretics; Ethambutol; Ethanol; Fructose; Humans; Levodopa; Nicotinic Acids; Pyrazinamide; Salicylates; Thiadiazoles; Uric Acid; Uricosuric Agents

1975

Other Studies

8 other study(ies) available for levodopa and salicylates

ArticleYear
Adverse interactions of drugs.
    The Medical letter on drugs and therapeutics, 1975, Feb-28, Volume: 17, Issue:5

    Topics: Anti-Bacterial Agents; Anticoagulants; Antidepressive Agents; Antihypertensive Agents; Barbiturates; Contraceptives, Oral, Synthetic; Digitalis Glycosides; Diuretics; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Ethanol; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuromuscular Nondepolarizing Agents; Salicylates; Sympathomimetics; Thyroid Hormones

1975
Letter: Possible analgesic action of L-dopa.
    The New England journal of medicine, 1975, May-29, Volume: 292, Issue:22

    Topics: Analgesics; Brain; Humans; Levodopa; Salicylates

1975
Letter: Variability in system for automated determination of dissolution rate.
    Journal of pharmaceutical sciences, 1975, Volume: 64, Issue:6

    Topics: Benzodiazepines; Chemical Phenomena; Chemistry; In Vitro Techniques; Levodopa; Salicylates; Tablets

1975
Effect of salicylate on the rectal absorption of lidocaine, levodopa, and cefmetazole in rats.
    Journal of pharmaceutical sciences, 1982, Volume: 71, Issue:8

    Topics: Animals; Biological Availability; Cefmetazole; Cephalosporins; Cephamycins; Infusions, Parenteral; Intestinal Absorption; Levodopa; Lidocaine; Male; Rats; Rats, Inbred Strains; Rectum; Salicylates; Salicylic Acid; Stimulation, Chemical

1982
Tyrosinase inhibitors from Anacardium occidentale fruits.
    Journal of natural products, 1994, Volume: 57, Issue:4

    Topics: Anacardic Acids; Basidiomycota; Kinetics; Levodopa; Monophenol Monooxygenase; Nuts; Oxidation-Reduction; Resorcinols; Salicylates; Structure-Activity Relationship

1994
L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion.
    Journal of neurochemistry, 2000, Volume: 74, Issue:3

    Topics: Animals; Cerebellum; Corpus Striatum; Gentisates; Hydroxybenzoates; Hydroxyl Radical; Injections; Levodopa; Male; Mesencephalon; Methamphetamine; Microdialysis; Osmolar Concentration; Oxidopamine; Rats; Rats, Sprague-Dawley; Salicylates; Substantia Nigra

2000
The parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) mediates release of l-3,4-dihydroxyphenylalanine (l-DOPA) and inhibition of l-DOPA decarboxylase in the rat striatum: a microdialysis study.
    Chemical research in toxicology, 2003, Volume: 16, Issue:10

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Aromatic Amino Acid Decarboxylase Inhibitors; Body Temperature; Chromatography, High Pressure Liquid; Dopa Decarboxylase; Hydroxyindoleacetic Acid; Levodopa; Male; Mannitol; Microdialysis; Neostriatum; Parkinsonian Disorders; Perfusion; Rats; Rats, Sprague-Dawley; Salicylates; Serotonin; Time Factors

2003
Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism.
    Brain research, 2010, Jul-16, Volume: 1344

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Male; Medial Forebrain Bundle; Mice; Mice, Inbred BALB C; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Salicylates

2010